Literature DB >> 678681

[A modified MOPP regimen in the treatment of Hodgkin's disease stage III B and IV (author's transl)].

F J Tigges, E Hiller, R M Schmülling, H D Waller, K Wilms.   

Abstract

In a retrospective study 80 patients with Hodgkin's disease of stage III B (n = 32) and IV (n = 48) were investigated, who had been treated with a modified MOPP regimen. 28 patients (35%) were previously untreated. A completed remission was reached in 51 patients, a partial remission in 16, and 13 patients failed to respond. 16 patients had died in the observation period. Complete remissions were twice as frequent with 90% in stage III as compared with 45% in stage IV. The group of patients surviving 4 years was 92% in stage III and 62% in stage IV.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 678681     DOI: 10.1007/BF01002106

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


  25 in total

1.  Status and perspectives in chemotherapy of Hodgkin's disease.

Authors:  E Frei
Journal:  Arch Intern Med       Date:  1973-03

2.  Chemotherapy of Hodgkin's disease. Maintenance therapy vs no maintenance after remission induction with combination chemotherapy.

Authors:  J K Luce; E Frei; E A Gehan; C A Coltman; R Talley; R W Monto
Journal:  Arch Intern Med       Date:  1973-03

3.  Sequential radiotherapy and chemotherapy in the treatment of Hodgkin's disease. A progress report.

Authors:  M R Moore; J M Bull; S E Jones; S A Rosenberg; H S Kaplan
Journal:  Ann Intern Med       Date:  1972-07       Impact factor: 25.391

4.  Definition of cure for Hodgkin's disease.

Authors:  E Frei; E A Gehan
Journal:  Cancer Res       Date:  1971-11       Impact factor: 12.701

5.  Combination chemotherapy in the treatment of advanced Hodgkin's disease.

Authors:  V T Devita; A A Serpick; P P Carbone
Journal:  Ann Intern Med       Date:  1970-12       Impact factor: 25.391

6.  The management of stages I, II, and III Hodgkin's disease with combined radiotherapy and chemotherapy.

Authors:  S A Rosenberg; H S Kaplan
Journal:  Cancer       Date:  1975-01       Impact factor: 6.860

7.  Recent trends in the medical treatment of Hodgkin's disease.

Authors:  G Bonadonna; C Uslenghi; R Zucali
Journal:  Eur J Cancer       Date:  1975-04       Impact factor: 9.162

8.  Staging and treatment of Hodgkin's disease.

Authors:  J L Amiel; J P Droz
Journal:  Eur J Cancer       Date:  1978-01       Impact factor: 9.162

9.  [Post-MOPP chemotherapy of Hodgkin's disease (author's transl)].

Authors:  R Osieka; U Bruntsch; W M Gallmeier; S Seeber; C G Schmidt
Journal:  Dtsch Med Wochenschr       Date:  1976-08-06       Impact factor: 0.628

10.  Second malignancies complicating Hodgkin's disease in remission.

Authors:  G P Canellos; J C Arseneau; V T DeVita; J Whang-Peng; R E Johnson
Journal:  Lancet       Date:  1975-04-26       Impact factor: 79.321

View more
  4 in total

1.  [Unusually long survival times in patients with advanced Hodgkin's disease (author's transl)].

Authors:  E Hiller; W Wilmanns; K Wilms
Journal:  Klin Wochenschr       Date:  1979-07-15

2.  [Stage IIIB and IVB Hodgkin's disease. Response to chemotherapy, relapses, survival rates (author's transl)].

Authors:  R Kuse; A Calavrezos; A Hinrichs; K Hausmann
Journal:  Klin Wochenschr       Date:  1981-07-01

3.  Prognostic factors in COPP-treated patients with Hodgkin's disease.

Authors:  W Gassmann; L Perenyi; N Schmitz; W Kayser; H Pralle; H Löffler
Journal:  Blut       Date:  1982-06

4.  [Results of treatment with ABVD in C-MOPP-resistant Hodgkin's disease (author's transl)].

Authors:  W Gassmann; L Perenyi; H Pralle; M Graubner; N Schmitz; H Löffler
Journal:  Klin Wochenschr       Date:  1981-03-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.